Zimbabwe has turned down a major American health deal valued at $367m (£272m) over five years because of Washington's request for sensitive information.
This rejection was revealed following a official document dated December was disclosed, indicating that President Emmerson Mnangagwa believed the arrangement was "unbalanced".
A government spokesperson has since clarified that the US was seeking health data for scientific study and commercial purposes but was unwilling to guarantee the benefits from any future vaccines.
"We will now turn to the challenging and unfortunate process of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had provided over $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for further talks to reach a agreement acceptable to all parties so the country's vital HIV treatment initiative can be sustained.
Wider Context
This rejection follows a similar situation in Kenya, where a high court blocked a related deal with the US after concerns were filed about the safety of citizens' medical information.
After returning to the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump stated its spending was "wasteful" and his administration was pursuing government-to-government agreements to boost openness and responsibility.
As per reports, 16 nations in Africa have so far signed these new agreements, constituting more than $18.3bn in new funding.
Specifics of the Rejected Agreement
This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration could have provided immense advantages for the people of Zimbabwe, particularly the 1.2 million presently on HIV treatment through American-funded initiatives," Tremont said.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"The proposal required Zimbabwe to share its genetic material and health information for a long time, with no equivalent assurance of benefiting from any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," his statement read.
"Put simply, our nation would supply the basic resources for scientific discovery with no assurance that the end products would be accessible to our population should a future health crisis arise."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting systems already set up through the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to deal with future pandemics.
"This system is designed to ensure that when a nation contributes its information, the benefits – including medicines and cures – are shared equitably, not commercialised solely by those with the capability to develop them."
These objections over the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to further discussions with our US partners on how future co-operation could be structured in a way that honours the independence and dignity of both nations."
Health Experts Response
Medical experts stated it acknowledged the government's concerns, but recommended that negotiations need to persist since a large portion of the country's HIV programmes were funded by international support.
"In cases where technical issues arise, such as those involving information security or agreement terms, these can frequently be resolved through detailed discussion and mutually agreed protections," the group said.
The halted deal highlights the ongoing tensions between receiving much-needed foreign assistance and safeguarding national sovereignty in an ever more interconnected world.